1 / 21

Cardiac arrhythmia

Cardiac arrhythmia . Primary quinidine–like drugs, sympathomimetic drugs, calcium channel blockers, β–blockers, digitalis, chloroquine Secondary to metabolic/electrolyte abnormalities salicylates, methanol, ethylene glycol. Cardiotoxic drugs . All patients should have

johana
Download Presentation

Cardiac arrhythmia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiac arrhythmia • Primary • quinidine–like drugs, sympathomimetic drugs, calcium channel blockers, β–blockers, digitalis, chloroquine • Secondary to metabolic/electrolyte abnormalities • salicylates, methanol, ethylene glycol

  2. Cardiotoxic drugs • All patients should have • oxygenation and protection of airway • decontamination of the GIT • atropine pre–medication • correction of electrolyte abnormalities • acid base balance • cardioversion when appropriate • consultation

  3. Cardiac arrest • Successful resuscitation has been well documented after 8 hours of CPR • Overdose patients usually have • a reversible cause for their arrest • good general health • novel treatments for arrhythmias • cerebral protection

  4. Antidotes: asystole & bradycardia • Atropine everything • Bicarbonate tricyclic antidepressants • Calcium calcium channel blockers • Diazepam chloroquine, organochlorines • Epinephrine everything, β–blockers • Fab fragments digoxin • Glucagon β–blockers, CCBs

  5. Cardiac case 1 • 18 yo female admitted 3 hours after self–poisoning with • 3.5 g of slow release verapamil (Isoptin SR) • 6 g of paracetamol • 4.5 g of tetracycline • 1 g of pseudoephedrine • On arrival in casualty • pr 120, BP 110/80, RR 20, afebrile • drowsy but oriented and cooperative

  6. Cardiac case 1 • GI decontamination • emesis before arrival • lavaged with return of green tablets • 50 g of charcoal with sorbitol repeated 4 h later • Investigations • ECG • sinus tachycardia with normal QRS width • serum paracetamol at 4 h was 38 µmol/l • hepatotoxicity > 1300 µmol/l at 4 hours

  7. Cardiac case 1 • In intensive care unit • 16 hours post overdose • BP fell to 70/40 and then 50/30 • PR 50 • oxygen saturation dropped to 75 % • ECG • absent p waves • prominent u waves • normal QRS duration and QT interval

  8. Cardiac case 1 • Treatment • IV atropine 0.6 mgs – no response • IV calcium gluconate • 6 g over 20 minutes • further 6 g over the next hour • pr 60, sinus rhythm, BP 100/80 • oxygen saturation > 95 % • infusion of 10% calcium gluconate at 2 G/h for 10 hours • she was also given 2.5 L IV fluids

  9. Cardiac case 1 • Outcome • non–cardiogenic pulmonary oedema • twenty four hours post admission • largely recovered , sinus rhythm PR 60, BP 115/70 • peak serum Ca was 4.8 (2.18–2.47 mmol/l) • serial verapamil levels at 6, 18, 22 and 46 hours were 616, 2374, 2518 and 1006 ng/ml • range during usual therapy • 100–300 ng/ml

  10. Cardiac case 2 • 38 yo female admitted after self–poisoning with • amitriptyline 2525 mg • dothiepin 1650 mg • Found unconscious with suicide note carefully documenting tablets • last seen 9 a.m., brought in by ambulance at 6 p.m. • later said she had read that 2.5 g was a lethal dose

  11. Cardiac case 2 • No past medical history • Depressed for several months, treated by a psychiatrist • On examination • absent gag • unconscious, flexes to pain • PR 40, BP 130/100, afebrile • hypoventilating, 02 saturation 94 % • flushed, dilated pupils, reduced bowel sounds

  12. Cardiac case 2 • Investigations • FBC • EUC • paracetamol level • ECG • CXR ? aspiration • GI decontamination • gastric lavage and activated charcoal

  13. Cardiac case 2 • Treatment and outcome • given NaHC03 IV • intubated and hyperventilated • IV normal saline • ABGs monitored to keep pH 7.5 • serial ECGs • prolonged unconsciousness • extubated 40 hours later • no long term sequelae

  14. Cardiac case 3 • 26 yo female • found unconscious by police in caravan • empty bottle of tablets with label removed • no relatives/other history available • On examination • PR 140, BP 120/80, afebrile • unconscious • GCS 6

  15. Cardiac case 3 • Investigations • ECG • QRS width 120 ms • PR interval 200 ms • CXR • aspiration pneumonia • Management • intubated, lavage, charcoal, antibiotics

  16. Cardiac case 3 • Outcome • sudden deterioration 2 hours later • bradycardia • asystole • unable to be resuscitated

  17. Tricyclic antidepressants • Ingestion of 15–20 mg/kg is potentially fatal • Mechanism of action • block re–uptake of noradrenaline and serotonin • competitive antagonists at H1 and H2 receptors • anticholinergic effects • membrane effects on sodium channel, quinidine–like effect

  18. Toxico–kinetics • Absorption and distribution • highly lipid soluble • rapidly absorbed • high volume of distribution • delayed absorption due to anticholinergic effect in GIT • pH dependent protein binding > 95% • large variation in amount of free TCA • a change in the pH from 7.38 to 7.50 produces a 21% reduction in free TCA

  19. TCA management • General • supportive care, ABG, ECG, electrolytes • lavage, charcoal with sorbitol/mannitol • CNS toxicity • seizures • IV diazepam • IV phenytoin (15–18 mg/kg) • anticholinergic delirium • benzodiazepines, haloperidol • seizure and fever consider physostigmine

  20. TCA management • Arrhythmias • plasma alkalinisation to pH ~ 7.5 • sodium bicarbonate, hyperventilation • drug treatment • acute • magnesium • sotalol • lignocaine • prophylactic • phenytoin • overdrive pacing

  21. TCA management • hypotension • volume expansion • pH correction • alpha agonists e.g. noradrenaline • inotropics e.g. dopamine, dobutamine

More Related